Physician profile
Shefin Mathew
NPI 1548887391
$1,136.93
in general payments reported to CMS, 2019-2025
12 companies · $733 in 2025
The $733 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $126 · 2022: $232 · 2024: $45.16 · 2025: $733.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $457 · Travel and Lodging: $322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $456.68 |
| Travel and Lodging | $321.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $459.90 | 2025 | |
| Medtronic, INC. | $164.45 | 2022 | |
| Depuy Synthes Sales INC. | $132.34 | 2021-2025 | Orthovisc, Monovisc, Truespan Orthocord |
| Globus Medical, INC. | $84.81 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $62.18 | 2025 | |
| Bioventus LLC | $48.62 | 2021-2022 | |
| Electronic Waveform Lab, INC. | $46.07 | 2025 | |
| Boston Scientific Corporation | $45.16 | 2024 | |
| Novus Surgical Consultants | $24.91 | 2025 | |
| Ibsa Pharma INC. | $24.42 | 2025 | Flector, Tirosint, Licart |
| Paratek Pharmaceuticals, INC. | $22.71 | 2025 | Nuzyra |
| Heraeus Medical, LLC. | $21.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shefin Mathew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.